Drugs / Sevoflurane
last change 10 days ago re-read 8 days ago

Sevoflurane

Other / unclassified targets KCNK10, KCNK18, KCNK2, KCNK3, KCNK9 via activation

Developed for
acute respiratory distress syndrome · delirium · coronary artery disorder · COVID-19 · cognitive disorder · heart disorder · acute kidney injury · cardiac valvular defect
+36 more · congenital heart disease · infectious disease with sepsis · ischemic disease · subjective cognitive decline · uterine disorder · acquired aneurysmal subarachnoid hemorrhage · acute lung injury · adult acute respiratory distress syndrome · atrial fibrillation · brain hypoxia - ischemia · brain injury · cerebral palsy · chronic obstructive pulmonary disease · hyperglycemia · hypotensive disorder · kidney failure · laryngeal disorder · lung disorder · major depressive disorder · mitochondrial disease · myocardial disorder · myocardial infarction · myocardial ischemia · non-small cell lung carcinoma · respiratory failure · subacute delirium · ulcer of lower limbs · acute myocardial infarction · acute transplant rejection · Alzheimer disease · breast neoplasm · chronic pain syndrome · colonic neoplasm · esophageal cancer · headache disorder · rectal neoplasm
Investigated by
University of Zurich · University Hospital, Clermont-Ferrand · Seoul National University Hospital · Kangbuk Samsung Hospital · Kaohsiung Medical University Chung-Ho Memorial Hospital · Astana Medical University
+211 more · Gangnam Severance Hospital · Huazhong University of Science and Technology · Triemli Hospital · University Hospital, Ghent · Vita-Salute San Raffaele University · Ain Shams University · Assistance Publique - Hôpitaux de Paris · Assistance Publique Hopitaux De Marseille · Austin Health · Benha University · Centre Hospitalier Universitaire Dijon · China International Neuroscience Institution · First Affiliated Hospital, Sun Yat-Sen University · Heidelberg University · Iuliu Hatieganu University of Medicine and Pharmacy · Kantonsspital Münsterlingen · Konkuk University Medical Center · Medical University of Gdansk · Ministry of Health, France · Nanjing Medical University · Negovsky Reanimatology Research Institute · Prof. Dr. I. Chiricuta Institute of Oncology · Pusan National University Yangsan Hospital · Regina Elena Cancer Institute · Ruhr University of Bochum · Second Affiliated Hospital, School of Medicine, Zhejiang University · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · Tanta University · Tao Zhang · The Cleveland Clinic · Trakya University · Tri-Service General Hospital (TSGH) · University Health Network, Toronto · University Hospital, Bordeaux · University of Malaya · Xijing Hospital · Yeungnam University College of Medicine · Yonsei University · AZ Sint-Jan AV · Abbott · Affiliated Cancer Hospital & Institute of Guangzhou Medical University · Air Force Military Medical University, China · Ajou University School of Medicine · Aristotle University Of Thessaloniki · Asan Medical Center · Ataturk University · Azienda Ospedaliera San Gerardo di Monza · Baxter (China) Investment Co. Ltd. · Baylor College of Medicine · Beijing Tiantan Hospital · Beni-Suef University · Beth Israel Deaconess Medical Center · Bicetre Hospital · Boston Children's Hospital · Brasilia University Hospital · Brigham and Women's Hospital · Brugmann University Hospital · C. R. Bard · Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine · Cantonal Hospital of St. Gallen · Centro Medico Campinas · Centro Medico Docente la Trinidad · Charles University, Czech Republic · Chaudhry Pervaiz Elahi Institute of Cardiology · Children's Hospital and Institute of Child Health, Multan · Children's Hospital of Fudan University · Children's Hospital of Philadelphia · China Medical University, China · Chonnam National University Hospital · Chosun University Hospital · Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Cukurova University · Department of Anaesthesiology and Intensive Care Medicine · DongGuk University · all 217 on the full record

Regulatory milestones approvals, filings & regulatory actions · 2 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansion US (FDA) ULTANE — 2001-03-30 fda.gov ↗
Approved US (FDA) ULTANE — 1995-06-07 fda.gov ↗

Trials 231 · started per year

today
US approved 1995
1
2
2
3
10
6
10
7
5
5
5
16
17
11
17
11
17
2
20
10
11
10
11
14
8
1995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 07 trials · 1 met primary
Phase 0 NCT06626711 Oct 2024 → Nov 2025 overdue cancer Saint Petersburg State University, Russia Active not recruiting No outcome recorded
Phase 0 NCT06044740 Jan 2024 → Jan 2026 amnestic disorder Keith M Vogt Completed No outcome recorded
Phase 0 NCT04950205 Jun 2021 → Dec 2022 arterial disorder, subjective cognitive decline Second Affiliated Hospital, School of Medicine, Zhejiang University Unknown Met primary
Phase 0 NCT04998253 Oct → Nov 2020 COVID-19, acute respiratory distress syndrome Unidad Temporal COVID-19 en Centro Citibanamex Completed No outcome recorded
Phase 0 NCT03498235 Mar 2018 → Jun 2020 — Obstetrics & Gynecology Hospital of Fudan University Unknown No outcome recorded
Phase 0 NCT02149927 Jun → Dec 2013 drug-induced mental disorder Technical University of Munich Completed No outcome recorded
Phase 0 NCT01511991 May 2009 → May 2014 heart valve disorder Konkuk University Medical Center Completed No outcome recorded
Phase 16 trials
Phase 1 NCT05742789 Nov 2021 → Jan 2023 aortic valve insufficiency, mitral valve insufficiency Astana Medical University Completed No outcome recorded
Phase 1 NCT05695287 Jan 2021 → Nov 2022 aortic valve insufficiency, coronary artery disorder, mitral valve insufficiency Astana Medical University Completed No outcome recorded
Phase 1 NCT04162535 Nov 2018 → Dec 2023 colorectal cancer Iuliu Hatieganu University of Medicine and Pharmacy Unknown No outcome recorded
Phase 1 NCT03569085 Jun → Dec 2018 heart disorder Kathirvel Subramaniam Completed No outcome recorded
Phase 1 NCT03311581 Sep 2017 → Jun 2021 end stage renal failure Kaohsiung Medical University Chung-Ho Memorial Hospital Completed No outcome recorded
Phase 1 NCT02188407 Jul 2008 → Sep 2013 — University Medical Centre Ljubljana Completed No outcome recorded
Phase 1/23 trials
Phase 1/2 NCT04771962 Jan 2020 → Dec 2021 — Universiti Sains Malaysia Completed No outcome recorded
Phase 1/2 NCT02918877 Jun 2017 → Dec 2018 acute lung injury Beth Israel Deaconess Medical Center Completed No outcome recorded
Phase 1/2 NCT00484575 Jun 2007 → Oct 2008 atrial fibrillation, myocardial disorder Karolinska Institutet Completed No outcome recorded
Phase 213 trials
Phase 2 NCT03643367 Jan 2026 → Feb 2027 expected — University of Zurich Not yet recruiting No outcome recorded
Phase 2 NCT03503578 May → Aug 2018 — Massachusetts General Hospital Completed No outcome recorded
Phase 2 NCT02839668 Aug 2016 → Sep 2019 breast cancer Iuliu Hatieganu University of Medicine and Pharmacy Completed No outcome recorded
Phase 2 NCT02946437 Nov 2015 → Dec 2019 acquired aneurysmal subarachnoid hemorrhage University of Zurich Withdrawn No outcome recorded Stop: Enrollment
Phase 2 NCT02202720 Aug → Nov 2014 — University Hospital, Clermont-Ferrand Completed No outcome recorded
Phase 2 NCT02042599 Jan 2014 → Feb 2016 acute kidney injury University Hospital, Clermont-Ferrand Unknown No outcome recorded
Phase 2 NCT02048683 Dec 2013 → Sep 2015 — University Hospital, Clermont-Ferrand Completed No outcome recorded
Phase 2 NCT02042612 Oct 2013 → Jan 2014 obesity disorder University Hospital, Clermont-Ferrand Completed No outcome recorded
Phase 2 NCT02284204 Jan 2012 → Aug 2014 — Federal University of Goiás Completed No outcome recorded
Phase 2 NCT01374633 Dec 2011 → Mar 2013 brain injury Assistance Publique - Hôpitaux de Paris Terminated No outcome recorded Stop: Business
Phase 2/31 trial
Phase 2/3 NCT00420693 Aug 2006 → May 2008 — Assistance Publique Hopitaux De Marseille Completed No outcome recorded
Phase 323 trials · 2 met primary · 3 missed
Phase 3 NCT07166991 Feb 2026 → Sep 2028 expected — University Hospital, Grenoble Recruiting No outcome recorded
Phase 3 NCT05849779 Jul 2023 → May 2026 overdue acute respiratory distress syndrome University Hospital, Clermont-Ferrand Recruiting No outcome recorded
Phase 3 NCT05615025 Jan → Jun 2023 neuromuscular junction disease Brugmann University Hospital Completed No outcome recorded
Phase 3 NCT05259631 Mar 2022 → Feb 2025 adult acute respiratory distress syndrome Negovsky Reanimatology Research Institute Suspended No outcome recorded Stop: Business
Phase 3 NCT04530188 Nov 2020 → May 2022 acute respiratory distress syndrome Bicetre Hospital Unknown No outcome recorded
Phase 3 NCT04415060 Jun 2020 → Mar 2026 overdue COVID-19, respiratory failure Sunnybrook Health Sciences Centre Active not recruiting No outcome recorded
Phase 3 NCT04235608 May 2020 → Oct 2023 acute respiratory distress syndrome University Hospital, Clermont-Ferrand Completed Missed primary
Phase 3 NCT04355962 Apr 2020 → Jun 2021 COVID-19, acute respiratory distress syndrome University of Zurich Completed Missed primary
Phase 3 NCT03841812 Jan → Jun 2020 — China International Neuroscience Institution Completed No outcome recorded
Phase 3 NCT05696509 Jan 2020 → Oct 2022 aortic valve insufficiency, mitral valve insufficiency Astana Medical University Completed No outcome recorded
Phase 468 trials · 4 met primary · 8 missed
Phase 4 NCT07673003 Jun → Nov 2025 — Children's Hospital and Institute of Child Health, Multan Completed No outcome recorded
Phase 4 NCT06779890 May 2025 → Sep 2026 overdue brain edema Georgia Tsaousi Recruiting No outcome recorded
Phase 4 NCT06773351 Feb → Dec 2025 overdue — Feng Gao Not yet recruiting No outcome recorded
Phase 4 NCT06560268 Nov 2024 → Jun 2025 overdue delirium, strabismus Cukurova University Not yet recruiting No outcome recorded
Phase 4 NCT07080528 Jul 2024 → Aug 2025 overdue curariform drugs toxicity Tamas Vegh, MD Enrolling by invitation No outcome recorded
Phase 4 NCT06371638 Jan → Mar 2024 — Udayana University Completed No outcome recorded
Phase 4 NCT05941494 Oct 2023 → Dec 2025 — Jason Chui Unknown No outcome recorded
Phase 4 NCT05926336 May 2023 → Jul 2026 overdue brain neoplasm, liver cancer, lung cancer, ovarian cancer Kaohsiung Medical University Chung-Ho Memorial Hospital Recruiting No outcome recorded
Phase 4 NCT05822817 May 2023 → Apr 2024 pituitary gland adenoma Peking Union Medical College Hospital Completed Missed primary
Phase 4 NCT05369949 Jan 2023 → Dec 2025 congenital heart disease Cliniques universitaires Saint-Luc- Université Catholique de Louvain Unknown No outcome recorded
Phase not applicable110 trials · 4 met primary · 4 missed
— NCT07601256 Aug 2026 → Dec 2030 expected infectious disease with sepsis, lung disorder Sixth Affiliated Hospital, Sun Yat-sen University Not yet recruiting No outcome recorded
— NCT07608900 Aug 2026 → Aug 2027 expected — TC Erciyes University Not yet recruiting No outcome recorded
— NCT07788157 Jul → Sep 2026 overdue — Tongji Hospital Recruiting No outcome recorded
— NCT07620782 May 2026 → Apr 2027 expected — Pusan National University Yangsan Hospital Recruiting No outcome recorded
— NCT07295158 Mar → Aug 2026 — Konya City Hospital Completed No outcome recorded
— NCT07325669 Jan 2026 → Jan 2027 expected — dilara gocmen Not yet recruiting No outcome recorded
— NCT07192549 Sep 2025 → Sep 2030 expected delirium General Hospital of Ningxia Medical University Not yet recruiting No outcome recorded
— NCT07152912 Sep 2025 → Mar 2026 overdue Halothane hepatitis, disorder of defective peroxisome oxidative status, gallbladder disorder Ain Shams University Recruiting No outcome recorded
— NCT06907823 Jun → Dec 2025 overdue — Pusan National University Yangsan Hospital Not yet recruiting No outcome recorded
— NCT07611240 Jun 2025 → Jun 2026 overdue obesity disorder Ataturk University Recruiting No outcome recorded
Comparator or background therapy353 trials
Phase 0 NCT05993039 Comparator Sep 2023 → Dec 2024 auditory system disorder Our Lady of the Lake Hospital Unknown No outcome recorded
Phase 0 NCT04016740 Background Aug 2019 → Feb 2020 coronary artery disorder, delirium Beth Israel Deaconess Medical Center Completed No outcome recorded
Phase 0 NCT02786329 Comparator Jun 2016 → Aug 2022 colorectal cancer Regional Institute of Gastroenterology and Hepatology Prof. Dr. Octavian Fodor Unknown No outcome recorded
Phase 1 NCT05025397 Background Sep 2021 → Mar 2022 — Takeda Completed No outcome recorded
Phase 1 NCT02973958 Background Feb 2017 → Jun 2018 balanitis, neuropathy, painful, paraphimosis Alberta Children's Hospital Completed Missed primary
Show all 353 trials opens the full record — a long page

Evidence & citations 26 cited values

Every value below carries the sentence it was read from. 586 sources stand behind the page.

FieldValueCited text
Known as sévoflurane “The general anesthesia group will receive sevoflurane (intervention drug) for induction and maintenance of general anesthesia, dose up to 8% inspired for duration of procedure...” NCT00756600 ↗
584

“In the inhalation anesthesia group, anesthesia is induced by pentothal sodium 4-6mg/kg and remifentanil 1 μg/kg, and then maintained with end-tidal sevoflurane concentration of...” NCT02813044 ↗

“Prospective clinical monocentric study in ICU with sedated ventilated obese patients with sevoflurane during 48 h with the AnaConda® system, establishing pharmacokinetic model...” NCT02042612 ↗

“This is a prospective, randomized controlled clinical trial evaluating the effects of ultra-low fresh gas flow (0.5 L/min) versus normal fresh gas flow (2.0 L/min) sevoflurane...” NCT07313969 ↗

“General anesthesia with intraoperative remifentanil infusion, sevoflurane maintenance, non-opioid co-analgesics, procedure-specific regional analgesia, and standardized...” NCT07665463 ↗

“The aim of this study was to compare the recovery of 2 Bispectral index (BIS)-guided anesthesia protocols combining sevoflurane-sufentanil (SS) or propofol-remifentanil (PR)...” PMID 23774117 ↗ Jan 2014

“Anesthesia maintenance: After endotracheal intubation, half of the patients will be randomized into Sevoflurane Group. The gas flow rate of Desflurane group is 2 L/min, 50%O2...” NCT02909413 ↗

“Anesthesia induction was performed using propofol and remifentanil, followed by maintenance with sevoflurane to ensure adequate anesthetic depth and hemodynamic stability...” NCT07097220 ↗

“Anesthesia will be maintained with Sevoflurane, Magnesium, Lidocaine, Ketamine, Decadron, Ondansetron, and Ketorolac at a concentration range/dose(s) based on the clinical need...” NCT03367988 ↗

“anesthesia was maintained by sevoflurane and remifentanil (0.1 μg kg-1 min-1), and primary anaesthetic namely sevoflurane was titrated to maintain intraoperative BIS values...” NCT01304953 ↗

“Aim of this trial is to compare propofol-based anaesthesia vs. sevoflurane-based anaesthesia induction in patients with cervical myelopathy receiving oral or nasal fiberoptic...” NCT01052337 ↗

Show 574 more sources

Known as inhalation anesthesia “inhalation anesthesia” NCT05926336 ↗
Known as Kaiteli “Anesthesia was maintained with sevoflurane (Inhalation Sevoflurane, Brand: Kaiteli” NCT07192549 ↗
Known as MR-6S4 ChEMBL registry synonym — accepted as the source's own label CHEMBL1200694 ↗
Known as NSC-760367 ChEMBL registry synonym — accepted as the source's own label CHEMBL1200694 ↗
Known as SEVO “Microdialysis probes were implanted in three groups of 10 patients each receiving either sevoflurane (SEVO), propofol (PRO), or spinal (SA) anaesthesia (for induction and maintenance).” PMID 18029344 ↗ Nov 2007
1

“While sevoflurane (SEVO) has been associated with potential renal risks” NCT06835010 ↗

Known as Sevocalm ChEMBL registry synonym — accepted as the source's own label CHEMBL1200694 ↗
Known as Sevoflo ChEMBL registry synonym — accepted as the source's own label CHEMBL1200694 ↗
Known as Sevoflurane (sevorane) “Sevoflurane (sevorane)” NCT02267980 ↗
Known as Sevoflurane, Sevocris (Cristalia Lab, Sao Paulo, Brazil) “Sevoflurane, Sevocris ® (Cristalia Lab, Sao Paulo, Brazil)” NCT02284204 ↗
Known as Sevoflurane/ Ultane 250mL/Bot “Sevoflurane/ Ultane 250mL/Bot” NCT05606692 ↗
Known as Sevoflurano ChEMBL registry synonym — accepted as the source's own label CHEMBL1200694 ↗
Known as sevofran “adjust the end-tidal sevoflurane (sevofran inhaler, Hana pharmacy, Korea) concentration maintaining the 40 \~ 50 BIS” NCT02609087 ↗
Known as Sevohale (previously known as sevocalm) ChEMBL registry synonym — accepted as the source's own label CHEMBL1200694 ↗
Known as SEVORANE “Administration of sevoflurane (SEVORANE) by inhalation until a maximal concentration of 4% of inspired gas.” NCT01006668 ↗
6

“inhalation introduction (Sevorane, 02,AIR (flow 2:2 l/min))” NCT02664142 ↗

“sevorane Quick fill (sevoflurane) : inhalation” NCT03772106 ↗

“Sevorane (sevoflurane, Abbott)” NCT00541918 ↗

“Propofol/sevorane” NCT07558226 ↗

NCT01905904 ↗

NCT01872884 ↗

Known as Sojourn ChEMBL registry synonym — accepted as the source's own label CHEMBL1200694 ↗
Known as ULTANE “1-3% sevoflurane (ULTANE®, AbbVie Inc., USA) in the Sevoflurane group.” NCT03263078 ↗
1

“Sevoflurane/Ultane” NCT05606692 ↗

Action Activate “Potassium channel subfamily K member 18 opener” CHEMBL1200694 ↗
4

“Potassium channel subfamily K member 10 opener” CHEMBL1200694 ↗

“Potassium channel subfamily K member 2 opener” CHEMBL1200694 ↗

“Potassium channel subfamily K member 9 opener” CHEMBL1200694 ↗

“Potassium channel subfamily K member 3 opener” CHEMBL1200694 ↗

Action Inhibit “The volatile anesthetics such as sevoflurane and desflurane are known to block the muscarinic receptor in different ways.” NCT02096224 ↗
Modality Other / unclassified “Sevoflurane (a volatile-inhaled anesthetic)” NCT00337051 ↗
Route Inhaled “combined sevoflurane and nitrous oxide inhalation” NCT00000262 ↗
Target KCNK10 “Potassium channel subfamily K member 10 opener” CHEMBL1200694 ↗
Target KCNK18 “Potassium channel subfamily K member 18 opener” CHEMBL1200694 ↗
Target KCNK2 “Potassium channel subfamily K member 2 opener” CHEMBL1200694 ↗
Target KCNK3 “Potassium channel subfamily K member 3 opener” CHEMBL1200694 ↗